These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30691802)

  • 1. Risk of Infectious Complications After Simultaneous Gastrointestinal and Liver Resections for Neuroendocrine Tumor Metastases.
    Acosta LF; Chacon E; Eman P; Dugan A; Davenport D; Gedaly R
    J Surg Res; 2019 Mar; 235():244-249. PubMed ID: 30691802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic surgery for metastases from neuroendocrine tumors.
    Sarmiento JM; Que FG
    Surg Oncol Clin N Am; 2003 Jan; 12(1):231-42. PubMed ID: 12735141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hepatic resections for non-colorectal, non-neuroendocrine metastases. Results of 32 hepatectomies in 27 patients].
    Hamy A; Mirallié E; Bizouarn P; Visset J; Paineau J
    Ann Chir; 2000 Feb; 125(2):124-30. PubMed ID: 10998797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Simultaneous Resection of Small Bowel Neuroendocrine Tumors with Synchronous Liver Metastases.
    Addeo P; Bertin JB; Imperiale A; Averous G; Terrone A; Goichot B; Bachellier P
    World J Surg; 2020 Jul; 44(7):2377-2384. PubMed ID: 32179974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liver resection for metastases not of colorectal, neuroendocrine, sarcomatous, or ovarian (NCNSO) origin: A multicentric study.
    Labgaa I; Slankamenac K; Schadde E; Jibara G; Alshebeeb K; Mentha G; Clavien PA; Schwartz M
    Am J Surg; 2018 Jan; 215(1):125-130. PubMed ID: 29061283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic Resection for Metastatic Neuroendocrine Cancer in Patients with Bone Metastases.
    Croome KP; Burns JM; G Que F; Nagorney DM
    Ann Surg Oncol; 2016 Oct; 23(11):3693-3698. PubMed ID: 27188296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
    Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
    Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly aggressive policy of hepatic resections for neuroendocrine liver metastases.
    Grazi GL; Cescon M; Pierangeli F; Ercolani G; Gardini A; Cavallari A; Mazziotti A
    Hepatogastroenterology; 2000; 47(32):481-6. PubMed ID: 10791218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resection of the Primary Gastrointestinal Neuroendocrine Tumor Improves Survival With or Without Liver Treatment.
    Lewis A; Raoof M; Ituarte PHG; Williams J; Melstrom L; Li D; Lee B; Singh G
    Ann Surg; 2019 Dec; 270(6):1131-1137. PubMed ID: 29746336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Major postoperative complications after pancreatic resection for P-NETS are not associated to earlier recurrence.
    Valente R; Lykoudis P; Tamburrino D; Inama M; Passas I; Toumpanakis C; Luong TV; Davidson B; Imber C; Malagò M; Rahman SH; Shankar A; Sharma D; Caplin M; Fusai G
    Eur J Surg Oncol; 2017 Nov; 43(11):2119-2128. PubMed ID: 28821361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synchronous resection of primary and liver metastases for neuroendocrine tumors.
    Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y
    Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgery Provides Long-Term Survival in Patients with Metastatic Neuroendocrine Tumors Undergoing Resection for Non-Hormonal Symptoms.
    Chakedis J; Beal EW; Lopez-Aguiar AG; Poultsides G; Makris E; Rocha FG; Kanji Z; Weber S; Fisher A; Fields R; Krasnick BA; Idrees K; Marincola-Smith P; Cho C; Beems M; Pawlik TM; Maithel SK; Schmidt CR; Dillhoff M
    J Gastrointest Surg; 2019 Jan; 23(1):122-134. PubMed ID: 30334178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining Perioperative Risk Associated with Simultaneous Resection of Primary Neuroendocrine Tumors and Synchronous Hepatic Metastases.
    Heidenreich BM; Kemp Bohan PM; Flor RJ; Bader JO; Vreeland TJ; O'Connor VV; Nelson DW
    World J Surg; 2021 Feb; 45(2):531-542. PubMed ID: 33151372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative systemic inflammation and infectious complications after resection of colorectal liver metastases.
    Neal CP; Mann CD; Garcea G; Briggs CD; Dennison AR; Berry DP
    Arch Surg; 2011 Apr; 146(4):471-8. PubMed ID: 21502458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Cherry picking", a multiple non-anatomic liver resection technique, as a promising option for diffuse liver metastases in patients with neuroendocrine tumours.
    Krausch M; Raffel A; Anlauf M; Schott M; Lehwald N; Krieg A; Topp SA; Cupisti K; Knoefel WT
    World J Surg; 2014 Feb; 38(2):392-401. PubMed ID: 24101025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in indication and results after resection of hepatic metastases from noncolorectal primary tumors: a single-institutional review.
    Yedibela S; Gohl J; Graz V; Pfaffenberger MK; Merkel S; Hohenberger W; Meyer T
    Ann Surg Oncol; 2005 Oct; 12(10):778-85. PubMed ID: 16132374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver resection for non-colorectal non-neuroendocrine metastases.
    Clarke NAR; Kanhere HA; Trochsler MI; Maddern GJ
    ANZ J Surg; 2018 Apr; 88(4):E313-E317. PubMed ID: 27490345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors.
    Que FG; Sarmiento JM; Nagorney DM
    Cancer Control; 2002; 9(1):67-79. PubMed ID: 11907468
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes of Cytoreductive Surgery for Metastatic Low-Grade Neuroendocrine Tumors in the Setting of Extrahepatic Metastases.
    Chan DL; Dixon M; Law CHL; Koujanian S; Beyfuss KA; Singh S; Myrehaug S; Hallet J
    Ann Surg Oncol; 2018 Jun; 25(6):1768-1774. PubMed ID: 29560571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic micrometastases are associated with poor prognosis in patients with liver metastases from neuroendocrine tumors of the digestive tract.
    Gibson WE; Gonzalez RS; Cates JMM; Liu E; Shi C
    Hum Pathol; 2018 Sep; 79():109-115. PubMed ID: 29763717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.